Metastasis-free survival is a strong surrogate for overall survival for men with localized prostate cancer, a meta-analysis shows. The intermediate outcome measure could help accelerate the evaluation of novel adjuvant therapies in this patient population.
from Cancer via ola Kala on Inoreader http://ift.tt/2yTwL8B
via IFTTT
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου